PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Terzah Horton, MD
Baylor College of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Orange County
Orange, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Miami
Miami, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- C.S. Mott Children'S Hospital
Ann Arbor, Michigan, United States
- Children'S Hospital and Clinics of Minnesota
Minneapolis, Minnesota, United States
- Columbia University Medical Center
New York, New York, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- University Hospitals Seidman Cancer Center
Cleveland, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Doernbecher Children'S Hospital
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- University of Texas, Southwestern
Dallas, Texas, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Texas Children'S Hospital/baylor University
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Feb 2019
- Primary completion
- 3 Dec 2023
- Completion
- 30 Jun 2025
- Last update posted
- 17 Jun 2025
- Registered enrollment
- 24
- Registry id
- NCT03817320
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.